PEYTON R HALL

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology WEST MONROE, LA NPI 1508869801

General Payments — all program years on this page

$324.12

  • Category: General Payments
  • Program years: PY2018
  • Record count: 16
  • As of (CMS publication): 2026-01-23

Latest program year (PY2018): $324.12 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2018) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $280.1013
Education $44.023

By paying entity

Latest program year (PY2018) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $145.924
PFIZER INC. $66.354
AMAG Pharmaceuticals, Inc. $44.023
ABBVIE INC. $16.461
BOSTON SCIENTIFIC CORPORATION $14.471
Duchesnay USA Incorporated $13.931
Astellas Pharma US Inc $11.651
Allergan Inc. $11.321

By program year

Program yearAmountRecords
2018 $324.1216

Records — PY2018 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
549119623 BOSTON SCIENTIFIC CORPORATION $14.47 02/19/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
559460969 AMAG Pharmaceuticals, Inc. $14.11 02/01/2018 Education Undisputed 01/23/2026 View at CMS
559460975 AMAG Pharmaceuticals, Inc. $17.01 03/19/2018 Education Undisputed 01/23/2026 View at CMS
559460979 AMAG Pharmaceuticals, Inc. $12.90 04/30/2018 Education Undisputed 01/23/2026 View at CMS
567861549 Amgen Inc. $13.18 02/12/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567861553 Amgen Inc. $105.64 02/06/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567861561 Amgen Inc. $14.47 04/16/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567861565 Amgen Inc. $12.63 05/14/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
570825823 AbbVie, Inc. $16.46 05/10/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
577172319 Duchesnay USA Incorporated $13.93 01/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
582700939 Astellas Pharma US Inc $11.65 01/10/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
596338075 Allergan Inc. $11.32 04/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
610519499 PFIZER INC. $13.31 05/21/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
610569061 PFIZER INC. $18.81 04/26/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
610742107 PFIZER INC. $14.98 03/07/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
610750731 PFIZER INC. $19.25 04/24/2018 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.